Fact-checked by Grok 2 weeks ago

Natural pacemaker

The (SA node), commonly known as the heart's natural pacemaker, is a specialized cluster of cardiac cells located at the junction of the and the in the wall of the right atrium. It functions as the primary initiator of the by spontaneously generating electrical impulses at a rate of 60 to 100 beats per minute in a resting , which propagate through the to coordinate atrial and ventricular contractions. This ensures rhythmic pumping of throughout the without external . Composed of pacemaker cells (P cells) interspersed with transitional cells and , the SA node exhibits unique electrophysiological properties that enable its pacemaker role. These cells undergo spontaneous through mechanisms involving the "funny current" (I_f) and intracellular calcium handling, creating a that triggers action potentials. Under normal conditions, the SA node dominates over subsidiary pacemakers like the , maintaining as the default cardiac pattern. The SA node's activity is finely regulated by the to adapt to physiological needs. Sympathetic stimulation via beta-1 adrenergic receptors increases the firing rate by enhancing activity, accelerating the heart during stress or exercise, while parasympathetic input through the slows it by hyperpolarizing cells, promoting rest. Hormonal influences, such as , can also modulate its function. Clinically, SA node dysfunction—often due to aging, , or ischemia—can result in bradyarrhythmias, sinus pauses, or sick sinus syndrome, where the node fails to generate or conduct impulses reliably. In such cases, the heart may rely on slower backup , leading to symptoms like or syncope, and artificial may be implanted to restore normal rhythm. Research continues to explore SA node cellular dynamics to improve treatments for conduction disorders.

Anatomy

Sinoatrial Node

The (SA node), also known as the sinus node, is a small cluster of specialized cardiomyocytes situated at the junction of the and the right atrium, specifically along the crest of the . This structure functions as the heart's primary natural , initiating electrical impulses that coordinate cardiac . Composed of a crescent-shaped mass of cells embedded in , the SA node spans a compact area beneath the epicardium in the upper posterior wall of the right atrium. The cellular makeup of the SA node includes a heterogeneous population of pacemaker cells, referred to as P cells, which are characterized by sparse myofibrils and a lack of well-organized sarcomeres, enabling their . These P cells are interspersed with transitional cells, which exhibit intermediate features between nodal and atrial myocytes and facilitate the conduction of impulses from the node to the surrounding atrial myocardium. The node also contains supporting non-myocytic elements, such as fibroblasts and components, that contribute to its structural integrity. Histologically, the SA node is distinguished by its rich innervation from autonomic fibers and a robust vascular supply essential for its function. Blood supply is provided by the SA nodal artery, which originates as a branch of the in approximately 60% of individuals and from the left artery in 40% of cases; in 5-10% of hearts, dual supply from both is present. The node's dimensions typically range from 10-20 mm in length, 2-3 mm in width, and 1-3 mm in thickness, encompassing a relatively small volume that houses thousands of specialized cells. During embryogenesis, the SA node develops from mesodermal progenitor cells in the region, the embryonic venous inflow tract that incorporates into the right atrium as the heart tube loops and remodels. This origin reflects the evolutionary conservation of pacemaker tissue at the venous pole of the heart, with molecular markers such as Tbx18 and Shox2 guiding its specification from second heart field and sinus venosus contributions.

Atrioventricular Node

The , serving as the heart's secondary , is situated in the right atrium within the triangle of Koch, a region bounded by the tendon of Todaro superiorly, the posteriorly, and the septal leaflet of the inferiorly, positioning it near the and just above the annulus. This strategic location allows it to receive electrical impulses from the atria while bridging conduction to the ventricles. In cases of failure, the AV node can assume function as an escape rhythm generator, typically at rates of 40-60 beats per minute. Structurally, the AV node is smaller than the , measuring approximately 1-3 mm in length and 1-2 mm in width, and comprises a small number of specialized nodal cells. Its cellular composition includes slow-conducting nodal cardiomyocytes, which are smaller and paler than typical working myocardial cells due to sparse myofibrils and abundant , transitioning distally to faster-conducting transitional cells at the His bundle interface. These nodal cells exhibit but at a slower intrinsic rate than the sinoatrial node, underscoring the AV node's subsidiary role. The AV node's blood supply derives primarily from the AV nodal artery, which originates as a branch of the in about 90% of individuals, with the remainder supplied by the left circumflex artery in cases of left coronary dominance. This arterial branch penetrates the node from its central fibrous body, ensuring nutrient delivery critical for its conduction properties. Preferential conduction to the AV node occurs through the atrial myocardium, primarily via faster-conducting regions such as the anterior pathway along the and Bachmann's bundle, and the posterior pathway near the . The concept of discrete internodal tracts remains debated and is not supported by histological evidence.

Electrophysiology

Pacemaker Potential

The pacemaker potential refers to the spontaneous phase 4 diastolic observed in cardiac pacemaker cells, such as those in the , which gradually raises the to initiate rhythmic action potentials. This process lacks a stable , distinguishing it from contractile myocytes, and relies on the interplay of several ionic currents to achieve . During phase 4, the in cells starts from a maximum diastolic potential of approximately -60 to -65 and slowly to around -40 . The primary driver is the funny current (I_f), an inward current activated by hyperpolarization below -40 to -45 and mediated by hyperpolarization-activated cyclic nucleotide-gated (HCN) channels, predominantly the HCN4 isoform in pacemaker tissues. I_f carries mainly Na⁺ ions inward at diastolic potentials, with a reversal potential near -10 to -20 , contributing to the initial slope of depolarization. Additional contributions include inward Ca²⁺ currents through T-type (Ca_v3.1/3.2) channels, which activate around -60 mV and accelerate in the mid-to-late phase, as well as the progressive decay of outward K⁺ currents that reduces hyperpolarizing influences. Unlike ventricular myocytes, which maintain a stable near -90 mV via strong inward K⁺ current (I_{K1}), pacemaker cells express minimal I_{K1}, allowing unchecked spontaneous driven by HCN channels. Upon reaching the threshold of approximately -40 , the pacemaker triggers the opening of voltage-gated Ca²⁺ channels, initiating phase 0 . Mathematically, the rate of change in during early phase 4 can be approximated by the contribution of I_f as: \frac{dV}{dt} \approx g_f (E_f - V) + I_{\text{other}} where g_f is the funny conductance, E_f \approx -10 is the reversal of I_f, V is the , and I_{\text{other}} represents additional currents. This model highlights I_f's role in setting the slope and firing rate.

Action Potential Phases

The action potential in natural pacemaker cells, such as those in the , differs markedly from that in ventricular myocytes, featuring a rapid upstroke followed by without the characteristic notch or plateau phases. Upon reaching the during phase 4 (as detailed in the section), the membrane undergoes phase 0 depolarization primarily driven by influx of Ca²⁺ through L-type voltage-gated calcium channels, rather than the fast ⁺ currents dominant in working myocardium. These channels, predominantly Cav1.2 isoforms, activate more slowly, resulting in a conduction of approximately 0.05 m/s within the node, which ensures coordinated but delayed propagation to atrial tissue. The upstroke peaks at around +10 mV, reflecting the limited amplitude due to the reliance on Ca²⁺ dynamics and sparse expression of voltage-gated ⁺ channels in pacemaker cells. Unlike ventricular action potentials, pacemaker potentials lack phases 1 and 2, avoiding the early notch and prolonged plateau; this absence stems from the minimal density of fast Na⁺ channels and reduced transient outward K⁺ currents, with greater dependence on Ca²⁺-mediated for excitability. A transient outward K⁺ current, mediated by Kv4.3 channels, is present but plays a minor role in these cells, contributing little to shaping the upstroke or early recovery. Repolarization occurs during phase 3, where outward K⁺ currents predominate to restore the membrane potential to approximately -60 mV over a duration of 100-200 ms. The rapid delayed rectifier current (I_{Kr}, via hERG channels) and slow delayed rectifier current (I_{Ks}, via KCNQ1/KCNE1 complexes) are key contributors, activating after inactivation of L-type Ca²⁺ channels to drive K⁺ efflux and terminate the action potential efficiently. This brief repolarization supports the high-frequency firing characteristic of pacemakers. A notable phenomenon associated with these phases is overdrive suppression, where pacing at rates faster than the intrinsic rhythm induces a transient hyperpolarization beyond -60 mV, delaying subsequent spontaneous activity. This arises from elevated intracellular Na⁺ accumulation during rapid depolarizations, which activates the electrogenic Na⁺/K⁺-ATPase pump to extrude Na⁺ in exchange for K⁺, generating a net outward (hyperpolarizing) current.

Regulation

Autonomic Influences

The plays a central role in modulating the activity of the (SAN), the heart's primary natural pacemaker, to dynamically adjust in response to physiological demands. The sympathetic and parasympathetic branches exert opposing influences: sympathetic activation accelerates the firing rate of SAN pacemaker cells, while parasympathetic input decelerates it. This neural control enables rapid adjustments to maintain hemodynamic stability, with the balance between the two systems determining the under normal conditions. Sympathetic innervation of the SAN arises from postganglionic fibers of the cardiac sympathetic nerves, which release norepinephrine that binds to β1-adrenergic receptors on pacemaker cells. This binding activates Gs proteins, stimulating to increase cyclic AMP () levels, which in turn activates (). PKA phosphorylates key ion channels, including hyperpolarization-activated cyclic nucleotide-gated (HCN) channels that conduct the funny current (If), thereby enhancing If and steepening the slope of the diastolic (phase 4) in SAN cells. Additionally, PKA increases L-type calcium (Ca²⁺) currents, further accelerating the rate of spontaneous depolarization and elevating , often up to 150 beats per minute () during heightened sympathetic activity such as exercise. In contrast, parasympathetic innervation is provided by vagal nerve fibers that release acetylcholine, which binds to M2 muscarinic receptors on SAN cells. This activates Gi proteins, inhibiting adenylyl cyclase to reduce cAMP levels and also directly opening G-protein inwardly rectifying potassium (GIRK) channels via the IK,ACh current. The resulting potassium efflux hyperpolarizes the membrane potential, slowing the phase 4 depolarization slope and reducing the spontaneous firing rate of pacemaker cells, which can lower heart rate to 40-60 bpm during states of rest or high vagal tone. Under normal physiological conditions, the intrinsic firing rate of the isolated is approximately 100 , but , the resting is modulated to 60-100 primarily due to dominant parasympathetic ( that suppresses the intrinsic rate, with sympathetic input providing baseline acceleration. This balance is evident in , where tonic vagal activity maintains a lower at rest, while sympathetic surges override it during stress. Reflex arcs, such as the reflex, further fine-tune this regulation: increased arterial pressure stimulates in the and , leading to enhanced vagal outflow and reduced sympathetic activity to slow and lower . Cardiac , as occurs in , disrupts this autonomic balance by eliminating both sympathetic and parasympathetic inputs, resulting in a higher resting of 90-110 bpm due to the loss of inhibitory vagal dominance and reliance on the unmodulated intrinsic rate. Over time, partial reinnervation may occur, but the initial denervated state highlights the critical role of parasympathetic tone in suppressing below intrinsic levels.

Hormonal Modulation

, particularly (T3) and thyroxine (T4), exert a significant influence on the by upregulating the expression and conductance of hyperpolarization-activated cyclic nucleotide-gated (HCN) channels, which carry the funny current (If) responsible for phase 4 depolarization. This enhancement accelerates the , elevating the basal over prolonged periods. In conditions of , where circulating T3 and T4 levels are elevated, this manifests as , with resting heart rates often exceeding 100 beats per minute and reaching up to 120 beats per minute or higher. Circulating catecholamines, such as epinephrine released from the during , provide systemic modulation of pacemaker activity through β-adrenergic receptors on cells, distinct from rapid neural inputs. Epinephrine binds primarily to β1-receptors, activating to increase cyclic AMP levels, which in turn phosphorylates HCN channels and enhances the funny current (If), steepening the slope of phase 4 depolarization and thereby increasing the firing rate. This systemic effect sustains elevated heart rates during prolonged , contributing to responses on timescales longer than acute sympathetic bursts. Electrolyte imbalances, as endocrine-influenced factors, also modulate pacemaker function by altering availability and membrane excitability. depolarizes the maximum diastolic potential in cells, inactivating sodium channels and reducing overall excitability, which slows the slope of phase 4 and diminishes spontaneous firing rates. Conversely, attenuates L-type calcium currents (ICaL), which are critical for the upstroke of phase 0 in pacemaker action potentials, leading to prolonged phases and overall slowing of activity. The renin-angiotensin system contributes to tonic modulation of via angiotensin II, which binds to AT1 receptors expressed on cells, eliciting a mild positive effect by enhancing calcium influx and activation. This interaction supports sustained increases in firing rate during states of volume expansion or , independent of acute neural reflexes. Aging progressively impairs the sinoatrial node's responsiveness to hormonal modulators, including and catecholamines, through downregulation of receptor density and signaling pathways like β-adrenergic responsiveness, leading to diminished effects. This reduced sensitivity, combined with intrinsic declines in cell , contributes to in the elderly, where the intrinsic —unaffected by autonomic influences—drops to approximately 60 beats per minute in older adults (mean age 65 years).

Clinical Aspects

SA Node Dysfunction

SA node dysfunction, also known as , refers to a spectrum of abnormalities in the sinoatrial (SA) node's ability to generate and conduct electrical impulses, leading to inappropriate heart rhythms. The primary clinical manifestation is sick sinus syndrome, characterized by alternating bradyarrhythmias and tachyarrhythmias due to progressive and scarring of the SA node and surrounding atrial tissue. This condition often results from age-related degenerative changes, with prevalence estimated at about 0.2% (1 in 600) among individuals over 65 years and higher in those over 70. Common causes include ischemia from occlusion of the SA nodal artery, which supplies blood to the and can lead to ischemic ; inflammatory processes such as post-viral that damage nodal cells; and infiltrative diseases like , where amyloid deposits impair nodal function. Idiopathic remains the most frequent etiology, particularly in older adults, often without a identifiable precipitant. Patients typically present with symptoms related to reduced , including syncope, fatigue, and , which may be intermittent and worsen over time. Electrocardiographic findings include with heart rates below 50 beats per minute or sinus pauses exceeding 3 seconds, reflecting impaired impulse generation. In severe cases, these pauses can lead to hemodynamic instability, though the may occasionally provide subsidiary pacemaking as a backup mechanism. Diagnosis relies on ambulatory monitoring such as Holter electrocardiography to capture episodic bradycardias or pauses during daily activities, with electrophysiological studies confirming dysfunction by measuring the sinus recovery time—the interval from cessation of atrial pacing to the first spontaneous sinus beat—which exceeds 1.5 seconds in abnormal cases. These tests help differentiate SA issues from other conduction disorders. Treatment for symptomatic SA node dysfunction primarily involves implantation of a permanent to maintain appropriate and rhythm, particularly in cases of severe or pauses. Dual-chamber pacemakers are often preferred to preserve atrioventricular synchrony. As of 2025, leadless pacemakers, including atrial-only devices, are emerging as safe alternatives for select patients with sick sinus syndrome, reducing risks associated with traditional leads. cases may require only monitoring. The term "sick sinus syndrome" was first described by Bernard Lown in 1967, initially in the context of arrhythmias following electrical cardioversion.

Ectopic Pacemakers

Ectopic pacemakers refer to focal regions within the heart exhibiting enhanced automaticity outside the sinoatrial (SA) node, primarily in the atria, atrioventricular (AV) junction, or Purkinje fibers, where they generate spontaneous depolarizations at rates typically ranging from 60 to 150 beats per minute under pathological conditions. These sites normally remain dormant due to suppression by the dominant SA node rhythm but can activate when their intrinsic firing rate exceeds that of the primary pacemaker, leading to premature beats or escape rhythms. The primary types of ectopic pacemakers include atrial ectopic foci, often originating from myocardial sleeves in the pulmonary veins, which are implicated in initiating (AF) through rapid bursts of impulses, and junctional escapes from the AV junction that emerge at rates of 40 to 60 beats per minute when SA node function falters. Atrial foci in the pulmonary veins, for instance, can produce high-frequency ectopic beats that trigger AF paroxysms, while junctional rhythms serve as protective escapes but may accelerate pathologically. Ventricular ectopic sites in the His-Purkinje system contribute to premature ventricular contractions, altering the duration beyond 0.10 seconds. Mechanistically, ectopic pacemakers arise from triggered activity involving afterdepolarizations, such as early afterdepolarizations (EADs) during the plateau phase or delayed afterdepolarizations (DADs) in , both driven by intracellular calcium overload that activates the sodium-calcium exchanger, generating inward currents sufficient to reach . Additionally, abnormal upregulation of the funny current (I_f), a hyperpolarization-activated cyclic nucleotide-gated channel current, steepens the diastolic depolarization slope in these foci, enhancing spontaneous firing akin to primary but in aberrant locations. These processes are exacerbated by factors like ischemia or sympathetic stimulation, promoting calcium accumulation and membrane instability. Clinically, ectopic pacemakers manifest as premature atrial contractions (PACs) originating from sites like the , which can propagate to induce supraventricular tachycardias, or as ventricular ectopy from , potentially escalating to via reentry. In the context of SA node suppression, junctional ectopic foci provide a backup rhythm but at slower rates, around 40 to 60 beats per minute for escapes, though acceleration to over 60 beats per minute signals dysfunction. Normally, the SA node's overdrive pacing prevents ectopic dominance by hyperpolarizing these sites post-activation, restoring suppression. Pharmacologically, β-blockers mitigate ectopic rates by attenuating sympathetic-driven and reducing calcium overload, thereby stabilizing in susceptible foci.

References

  1. [1]
    Physiology, Sinoatrial Node - StatPearls - NCBI Bookshelf
    The main function of the SA node is to act as the heart's normal pacemaker. ... Hence, the SA node is referred to as the heart's natural pacemaker. Go to ...
  2. [2]
    Heart Conduction System (Cardiac Conduction) - Cleveland Clinic
    Your sinoatrial (SA) node is your heart's natural pacemaker. It sends the electrical impulses that start your heartbeat. When your sinoatrial node isn't ...
  3. [3]
    What is the heart's natural pacemaker? - MedicalNewsToday
    Aug 31, 2022 · The sinoatrial (SA) node is the natural pacemaker of the heart. It generates electrical impulses that cause the heart's chambers to contract, ...
  4. [4]
    Pacemaker - Mayo Clinic
    Jun 4, 2025 · The sinus node also is called the heart's natural pacemaker. It can become weak as a person gets older. A pacemaker may have two parts: Pulse ...Overview · Why It's Done · What You Can Expect
  5. [5]
    Secrets of the coupled clock behind the heart's natural pacemaker ...
    Jul 3, 2018 · Thus, the SA node acts as the body's natural pacemaker, setting the rhythm of a normal beat. Malfunctions in the SA node's electrical signaling ...<|control11|><|separator|>
  6. [6]
    Sinoatrial node: definition, location, function - Kenhub
    Sinoatrial node ; Structure, Node of specialized cardiac muscle cells (pacemaker cells) located just beneath the epicardium in the wall of the right atrium.Missing: dimensions developmental
  7. [7]
    Sinoatrial Node - an overview | ScienceDirect Topics
    Sinoatrial node is a specialized group of myocardial conducting cells located in the superior and posterior walls of the right atrium close to the opening of ...Missing: composition dimensions origin
  8. [8]
    The sinoatrial node, a heterogeneous pacemaker structure
    From this, assuming a typical SA node cell is 6 μm in diameter and 20 μm in length with a surface area of 1000 μm2, they calculated the total surface area of ...Abstract · Introduction · Electrical coupling in the SA... · Electrical heterogeneity of...
  9. [9]
    Role of sinoatrial node architecture in maintaining a balanced ...
    The sinoatrial node (SAN), located in the right atrium, serves as the primary site for initiation of the normal heartbeat (sinus rhythm) (Figure 1). Together ...Missing: origin | Show results with:origin
  10. [10]
    Anatomy, Thorax, Sinoatrial Nodal Artery - StatPearls - NCBI Bookshelf
    Dec 9, 2023 · The sinoatrial nodal artery is a branch of the main coronary arteries, or its derivatives, which supplies blood to the heart's pacemaker, the sinoatrial node.Missing: composition dimensions
  11. [11]
    Anatomical Variations in the Sinoatrial Nodal Artery: A Meta ...
    The most common origin of the SANa was from the right coronary artery (RCA), found in 68.0% (95%CI:55.6–68.9) of cases, followed by origin from the left ...Missing: percentage | Show results with:percentage
  12. [12]
    Three-Dimensional Functional Anatomy of Human Sinoatrial node ...
    Multiple studies have described the 3D structure of the human SAN, which can be between ~11 to 30mm in length, ~2-6mm width and a thickness of ~2.2-2.6mm ( ...
  13. [13]
    Development of the Cardiac Conduction Tissue in Human Embryos ...
    Although it is generally believed that the sinoatrial node is derived from the sinus venosus or sinoatrial transition, the role of the sinus venosus in the ...
  14. [14]
    sinus venosus progenitors separate and diversify from the first and ...
    The sinus node receives a contribution of cells from an area of overlap between the Tbx18+ sinus venosus progenitors and the Isl1+ second heart field ...Abstract · Introduction · Results · Discussion
  15. [15]
    Atrioventricular Node - StatPearls - NCBI Bookshelf - NIH
    The atrioventricular (AV) node is a small structure in the heart, located in the Koch triangle,[1] near the coronary sinus on the interatrial septum.Definition/Introduction · Issues of Concern · Clinical Significance
  16. [16]
    ANATOMY AND ELECTROPHYSIOLOGY OF THE HUMAN AV NODE
    Anatomically, the AV node is located within the triangle of Koch,2 a region located at the base of the right atrium defined by the following landmarks: the ...
  17. [17]
    Atrioventricular (AV) node: definition,location, function | Kenhub
    Structure. The atrioventricular node is an oblique, oval-shaped collection of cells located in the wall of the posteroinferior region of the interatrial septum ...Missing: composition | Show results with:composition
  18. [18]
    Structure‐function relationship in the AV junction - Efimov - 2004
    Sep 14, 2004 · In the normal heart, the atrioventricular node (AVN) is part of the sole pathway between the atria and ventricles.Morphologic And... · Molecular Basis Of... · Connexin Hypothesis Of...Missing: composition | Show results with:composition
  19. [19]
    Isolation and Characterization of Atrioventricular Nodal Cells From ...
    Oct 14, 2011 · The AV node is localized within the triangle of Koch, bordered by the coronary sinus, tendon of Todaro, and tricuspid valve. Within this ...
  20. [20]
  21. [21]
    Anatomy, Thorax, Heart Coronary Arteries - StatPearls - NCBI - NIH
    The RCA supplies blood to the right side of the heart. The sinoatrial nodal branch of the RCA provides blood to the SA node, and the atrioventricular nodal ...
  22. [22]
    Circulation of Blood through the Heart (Anatomical Pathway) |
    The SA node is perfused by the RCA in approximately 55% of the population, and the AV node is perfused by the RCA in approximately 90% of the population.Missing: source:
  23. [23]
    Overview of Cardiac Conduction - Conduction System Tutorial
    In general, the atrioventricular node is located in the so-called floor of the right atrium, over the muscular part of the interventricular septum, inferior to ...
  24. [24]
    Conduction System of the Heart - Medscape Reference
    Feb 3, 2025 · The SA node is a spindle-shaped structure composed of a fibrous tissue matrix with closely packed cells. It is an elongated, three-dimensional ...Missing: composition origin
  25. [25]
    Internodal conduction pathways: revisiting a century-long debate on ...
    Internodal conduction pathways are the communication apparatus of the cardiac conduction system conveying sinus node action potentials (APs) to the ...
  26. [26]
    The Role of the Funny Current in Pacemaker Activity
    Feb 19, 2010 · The degree of activation of the funny current determines, at the end of an action potential, the steepness of phase 4 depolarization; hence, the ...
  27. [27]
    HCN Channels and Heart Rate - PMC - PubMed Central - NIH
    Hyperpolarization and Cyclic Nucleotide (HCN) -gated channels represent the molecular correlates of the “funny” pacemaker current (If), a current activated by ...
  28. [28]
    Cardiac Ion Channels | Circulation: Arrhythmia and Electrophysiology
    Apr 1, 2009 · Phase 4 diastolic depolarization is characteristic of pacemaker cells. Many ion channels contribute to phase 4 depolarization: the K+ channel ...
  29. [29]
    Sinoatrial Node Action Potentials - CV Physiology
    Cells within the sinoatrial (SA) node are the primary pacemaker site within the heart. These cells are characterized as having no true resting potential.Missing: 5000-20000 | Show results with:5000-20000
  30. [30]
    Distinct localization and modulation of Cav1.2 and Cav1.3 L-type ...
    In the sinoatrial node (SAN), Cav1 voltage-gated Ca2+ channels mediate L-type currents that are essential for normal cardiac pacemaking. Both Cav1.2 and Cav1.3 ...
  31. [31]
    Current aspects of the basic concepts of the electrophysiology of the ...
    Phase 4 is the spontaneous depolarization (pacemaker potential) that triggers the AP once the membrane potential reaches a threshold between −60 and − 40 mV.
  32. [32]
    Potassium channels in the sinoatrial node and their role in heart rate ...
    Oct 9, 2018 · Potassium channels play key roles in determining SAN repolarisation and the behaviour of the pacemaker potential.Missing: phases IKs
  33. [33]
    Cardiac Action Potentials - CV Pharmacology
    Action potential phases: ; Phase 0: Rapid depolarization - ↑ Na+ and ↓ K+ conductance ; Phase 1: Initial repolarization - ↓ Na+ and ↑ K+ conductance ; Phase 2: ...Missing: L- type Cav1. IKr
  34. [34]
    Characterisation of the transient outward K + current in rabbit ...
    Transient outward K+ current, Ito, characterised by rapid activation and inactivation and sensitivity to 4-aminopyridine (4-AP), has been recorded in cells from ...
  35. [35]
    Characteristics of the Delayed Rectifier Current (IKr and IKs) in ...
    Several currents contribute to repolarization of the cardiac action potential. In the ventricle, three major outward K+ currents are thought to be involved: the ...
  36. [36]
    Overdrive Suppression - CV Physiology
    This increased sodium stimulates the Na-K-ATPase (increases its activity) to expel more sodium from the cell in exchange for potassium (see figure).
  37. [37]
    Overview of Basic Mechanisms of Cardiac Arrhythmia - PMC
    A possible mechanism of overdrive suppression is intracellular accumulation of Na leading to enhanced activity of the sodium pump (sodium-potassium adenosine ...
  38. [38]
    The Autonomic Nervous System Regulates the Heart Rate through ...
    Sep 27, 2016 · Sinoatrial nodal cells (SANCs) generate spontaneous action potentials (APs) that control the cardiac rate. The brain modulates SANC automaticity ...
  39. [39]
    Neurohumoral Control of Sinoatrial Node Activity and Heart Rate
    The parasympathetic branch of the ANS counterbalances sympathetic effects. Parasympathetic neurons release ACh, which binds to muscarinic receptors in the ...Abstract · San Automaticity · Neurotransmitters and... · Autocrine, Paracrine, and...
  40. [40]
    The G-protein–gated K+ channel, IKACh, is required for regulation of ...
    Abstract. Parasympathetic regulation of sinoatrial node (SAN) pacemaker activity modulates multiple ion channels to temper heart rate.Missing: M2 | Show results with:M2
  41. [41]
    Autonomic and endocrine control of cardiovascular function - PMC
    Negative chronotropic effect (decrease in heart rate): The vagus nerve directly innervates the sinoatrial node; when activated, it serves to lower the heart ...
  42. [42]
    Control of Heart Rate - CV Physiology
    Heart rate is decreased below the intrinsic rate, primarily by activation of the vagus nerve innervating the SA node. Normally, at rest, there is significant ...
  43. [43]
    Physiology, Baroreceptors - StatPearls - NCBI Bookshelf
    Nerve impulses from arterial baroreceptors are tonically active; increases in arterial blood pressure will result in an increased rate of impulse firing.
  44. [44]
    Slowing Sinus Tachycardia in Heart Transplant Recipients: Is It Time?
    The “normal” range of resting HR in heart transplant recipients is not clearly defined but generally a value between 90 and 110 beats per minute (bpm) is ...
  45. [45]
    Exercise after heart transplantation: An overview - PubMed Central
    Dec 24, 2013 · The absence of parasympathetic activity is clearly evident in the denervated heart, which has an elevated resting HR, often more than 100 bpm[70] ...
  46. [46]
    Thyroid hormone increases the conductance density of f-channels in ...
    In hyperthyroidism, the main cardiac manifestation is an increase in resting heart rate with a great degree of sinus tachycardia. As the pacemaker current, ...Missing: T4 HCN expression
  47. [47]
    Thyroid Hormone Action in the Heart - Oxford Academic
    Heart rate effects are mediated by T3-based increases in the pacemaker ion current if in the sinoatrial node as mentioned above. The L-type calcium channel ...
  48. [48]
    Thyroid Disease and the Heart | Circulation
    Oct 9, 2007 · Thyroid hormone increases basal metabolic rate in almost every tissue and organ system in the body, and the increased metabolic demands lead ...
  49. [49]
    The funny current I f is essential for the fight-or-flight response in ...
    Oct 28, 2022 · Sympathetic neurons stimulate sinoatrial myocytes (SAMs) by activating β adrenergic receptors (βARs) and increasing cAMP. The funny current (If) ...Introduction · Materials and methods · Results · Discussion
  50. [50]
    The Electrophysiology of Hypo- and Hyperkalemia - PMC
    Hyperkalemia also depolarizes resting membrane potential, which first accelerates but then slows CV at [K+]o >8 mmol/l, manifested electrocardiographically ...
  51. [51]
    Hypocalcemia-Induced Slowing of Human Sinus Node Pacemaking
    Using a computational model, we show that hypocalcemia has a pronounced bradycardic effect in isolated human sinus node cells with healthy electrophysiology.
  52. [52]
    Mechanisms of angiotensin II chronotropic effect in anaesthetized ...
    This work has demonstrated that angiotensin II exerts in vivo a significant positive chronotropic effect that is mediated via AT1 receptors located in the ...
  53. [53]
    Characterization of angiotensin II receptor subtypes in rat heart.
    Angiotensin II exerts positive inotropic and chronotropic effects on the mammalian heart by binding to specific membrane receptors.
  54. [54]
    Cardiac Pacemaker Activity and Aging - PMC - PubMed Central
    Decreased maximal heart rate with aging is related to reduced β-adrenergic responsiveness but is largely explained by a reduction in intrinsic heart rate. J ...Missing: hormones | Show results with:hormones
  55. [55]
    Decreased maximal heart rate with aging is related to reduced β ...
    A decrease in maximal exercise heart rate (HR max ) is a key contributor to reductions in aerobic exercise capacity with aging.
  56. [56]
    Sick Sinus Syndrome - StatPearls - NCBI Bookshelf - NIH
    Sick sinus syndrome, also known as sinus node dysfunction, is a disorder of the sinoatrial node caused by impaired pacemaker function and impulse transmission.Continuing Education Activity · Etiology · Evaluation · Treatment / Management
  57. [57]
    Sinus Node Dysfunction - AAFP
    The incidence of sinus node dysfunction is 0.8 per 1,000 person-years and is expected to double by 2060 due to the aging population.
  58. [58]
    Sick Sinus Syndrome - DynaMed
    Mar 7, 2022 · Sick sinus syndrome (SSS) represents a spectrum of symptoms and heart rhythm abnormalities related to abnormalities in sinus node and atrial impulse formation.
  59. [59]
    Sinus Node Dysfunction: Background, Etiology, Pathophysiology
    Jul 8, 2025 · Although the term "sick sinus syndrome" (SSS) was first used to describe the sluggish return of SA nodal activity following electrical ...Missing: Lown 1966<|control11|><|separator|>
  60. [60]
    Electrophysiological Manifestations of Cardiac Amyloidosis: JACC
    Oct 19, 2021 · ... disease course. Sinus Node Dysfunction. Sinus node dysfunction (SND) is defined as an inability of the sinoatrial node to generate a heart ...
  61. [61]
    Sick sinus syndrome - Symptoms & causes - Mayo Clinic
    Sick sinus syndrome causes slow heartbeats, pauses (long periods between heartbeats) or irregular heartbeats (arrhythmias). Sick sinus syndrome is relatively ...Missing: prevalence | Show results with:prevalence
  62. [62]
    Sinus Node Dysfunction - StatPearls - NCBI Bookshelf
    Sinus node dysfunction is a disease that is characterized by the inability of the sinoatrial node of producing an adequate heart rate that meets the physiologic ...
  63. [63]
    Electrophysiologic Study Interpretation - StatPearls - NCBI Bookshelf
    Mar 28, 2025 · The EP evaluation of sinus node dysfunction includes measuring the sinus node recovery time (SNRT) and the sinoatrial conduction time (SACT).Continuing Education Activity · Anatomy and Physiology · Technique or Treatment
  64. [64]
    Sinus Node Dysfunction Workup - Medscape Reference
    Jul 8, 2025 · In most patients, ambulatory ECG monitoring for an extended period of time (typically 2-4 weeks but potentially longer) has the greatest yield and allows for ...
  65. [65]
    Diagnosis and Treatment of Sick Sinus Syndrome - AAFP
    Apr 15, 2003 · Causes of Sick Sinus Syndrome​​ Symptoms, which may have been present for months or years, can include syncope, palpitations, and dizziness, as ...Abstract · Clinical Manifestations · Diagnosis · Treatment
  66. [66]
    Entry - #608567 - SICK SINUS SYNDROME 1; SSS1 - (OMIM.ORG)
    History. The sick sinus syndrome was originally described by Lown (1967) as a complicating arrhythmia following cardioversion.
  67. [67]
    Ectopic Pacemaker - an overview | ScienceDirect Topics
    An ectopic pacemaker is defined as a subsidiary pacemaker that discharges impulses at a rate faster than the sinus node due to enhanced automaticity, ...
  68. [68]
    Ectopic Foci - CV Physiology
    Ectopic foci are abnormal pacemaker sites within the heart (outside the SA node) that display automaticity. Their pacemaker activity, however, is normally ...Missing: mechanisms types clinical review
  69. [69]
    Initiation of Atrial Fibrillation by Ectopic Beats Originating From the ...
    Ectopic beats from PVs can initiate AF, and β-adrenergic receptor blocker, calcium channel blockers, and sodium channel blockers can suppress these ectopic ...
  70. [70]
    Spontaneous Initiation of Atrial Fibrillation by Ectopic Beats ...
    Sep 3, 1998 · The pulmonary veins are an important source of ectopic beats, initiating frequent paroxysms of atrial fibrillation. These foci respond to treatment with radio- ...
  71. [71]
    Calcium Signaling and Cardiac Arrhythmias | Circulation Research
    Jun 9, 2017 · Ectopic (triggered) activity is primarily caused by (A) early afterdepolarizations (EADs) that occur mainly during bradycardia or after a pause, ...Missing: pacemakers | Show results with:pacemakers
  72. [72]
    Circulation Research Thematic Synopsis: Cardiac Arrhythmias
    ... afterdepolarizations (EADs), triggered activity and recurrent SVF. ... The Role of the Funny Current in Pacemaker Activity [Review]; DiFrancesco.
  73. [73]
    Junctional Rhythm - StatPearls - NCBI Bookshelf - NIH
    Jul 7, 2025 · Junctional escape rhythm: Heart rate between 40 and 60 bpm. Accelerated junctional rhythm: Heart rate between 60 and 100 bpm. Junctional ...Continuing Education Activity · Introduction · Evaluation · Treatment / Management